StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$3.01−0.37 (-10.81%)

Close on Nov 17, 2026Market cap $58.22MP/E –Yield –

Corbus Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

Corbus Pharmaceuticals's operating margin for the twelve months ending Mar 31, 2022 was -20990.2%. For fiscal 2021 it was -6350.1%, against -3119.2% the year before. The highest annual figure on record is -213.3% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 2021-6350.1%−3230.9
FY2020Dec 31, 2020-3119.2%−2905.9
FY2019Dec 31, 2019-213.3%+963.5
FY2018Dec 31, 2018-1176.8%+157.7
FY2017Dec 31, 2017-1334.4%−288.9
FY2016Dec 31, 2016-1045.6%+319.9
FY2015Dec 31, 2015-1365.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2021Sep 30, 2021-14257.1%−11496.4
Q2 FY2021Jun 30, 2021-12230.0%+1089.1
Q1 FY2021Mar 31, 2021-2379.4%−683.3
Q4 FY2020Dec 31, 2020-3162.0%−2105.4
Q3 FY2020Sep 30, 2020-2760.7%−1791.6
Q2 FY2020Jun 30, 2020-13319.1%−13325.0
Q1 FY2020Mar 31, 2020-1696.0%−289.5
Q4 FY2019Dec 31, 2019-1056.5%−143.8
Q3 FY2019Sep 30, 2019-969.1%+396.6
Q2 FY2019Jun 30, 20195.9%+1457.7
Q1 FY2019Mar 31, 2019-1406.5%−158.2
Q4 FY2018Dec 31, 2018-912.7%−39.1
Q3 FY2018Sep 30, 2018-1365.7%+716.5
Q2 FY2018Jun 30, 2018-1451.9%−875.8
Q1 FY2018Mar 31, 2018-1248.4%+767.4
Q3 FY2017Sep 30, 2017-873.6%−155.3
Q2 FY2017Jun 30, 2017-2082.2%–
Q1 FY2017Mar 31, 2017-576.1%–
Q4 FY2016Dec 31, 2016-2015.7%–
Q3 FY2016Sep 30, 2016-718.3%–

More Corbus Pharmaceuticals figures

See a number that looks wrong?